The Effect of Naldemedine on Opioid-induced Bowel Dysfunction

Clinical trial NCT06334198 · UNKNOWN

Trial details

NCT number: NCT06334198
Sponsor: Asbjørn Mohr Drewes
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Opioid-Induced Bowel Dysfunction Constipation

Start date: 2024-03-12
Primary completion: 2025-03-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.